BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32738155)

  • 1. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
    Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
    Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
    Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
    J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3
    Mitchell J; Kelly J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
    Clin Immunol; 2020 Jun; 215():108418. PubMed ID: 32283322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
    Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
    Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
    Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
    J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.
    Shanmugam V; Craig JW; Hornick JL; Morgan EA; Pinkus GS; Pozdnyakova O
    Am J Surg Pathol; 2017 Oct; 41(10):1390-1396. PubMed ID: 28622183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.
    Alexandrescu S; Tatevian N; Czerniak BA; Covinsky MH; Burns NK; Brown RE
    Int J Clin Exp Pathol; 2012; 5(6):503-11. PubMed ID: 22949932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival.
    Nagorsen D; Voigt S; Berg E; Stein H; Thiel E; Loddenkemper C
    J Transl Med; 2007 Nov; 5():62. PubMed ID: 18047662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the Treatment of Adult Langerhans Cell Histiocytosis --Review].
    Tian ZZ; Cui YJ; Peng HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):970-974. PubMed ID: 35680836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
    Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
    Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
    Berres ML; Merad M; Allen CE
    Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Langerhans cells in Langerhans cell histiocytosis.
    Geissmann F; Lepelletier Y; Fraitag S; Valladeau J; Bodemer C; Debré M; Leborgne M; Saeland S; Brousse N
    Blood; 2001 Mar; 97(5):1241-8. PubMed ID: 11222366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.
    Tong C; Jia X; Jia Y; He Y
    Int J Clin Exp Pathol; 2014; 7(6):3166-73. PubMed ID: 25031736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.
    Senechal B; Elain G; Jeziorski E; Grondin V; Patey-Mariaud de Serre N; Jaubert F; Beldjord K; Lellouch A; Glorion C; Zerah M; Mary P; Barkaoui M; Emile JF; Boccon-Gibod L; Josset P; Debré M; Fischer A; Donadieu J; Geissmann F
    PLoS Med; 2007 Aug; 4(8):e253. PubMed ID: 17696642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte sub-populations and non-Langerhans' cell monocytoid cells in pulmonary Langerhans' cell histiocytosis.
    Nagarjun Rao R; Chang CC; Tomashefski JF
    Pathol Res Pract; 2008; 204(5):315-22. PubMed ID: 18337020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
    Lim KPH; Milne P; Poidinger M; Duan K; Lin H; McGovern N; Abhyankar H; Zinn D; Burke TM; Eckstein OS; Chakraborty R; Sengal A; Scull B; Newell E; Merad M; McClain KL; Man TK; Ginhoux F; Collin M; Allen CE
    Blood Adv; 2020 Jan; 4(1):87-99. PubMed ID: 31899802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung.
    Colasante A; Poletti V; Rosini S; Ferracini R; Musiani P
    Am Rev Respir Dis; 1993 Sep; 148(3):752-9. PubMed ID: 7690210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent Lack of
    Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
    Front Immunol; 2019; 10():3045. PubMed ID: 31998317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children.
    Zeng K; Ohshima K; Liu Y; Zhang W; Wang L; Fan L; Li M; Li X; Wang Z; Guo S; Yan Q; Guo Y
    Hematol Oncol; 2017 Dec; 35(4):845-851. PubMed ID: 27597420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
    Berres ML; Lim KP; Peters T; Price J; Takizawa H; Salmon H; Idoyaga J; Ruzo A; Lupo PJ; Hicks MJ; Shih A; Simko SJ; Abhyankar H; Chakraborty R; Leboeuf M; Beltrão M; Lira SA; Heym KM; Bigley V; Collin M; Manz MG; McClain K; Merad M; Allen CE
    J Exp Med; 2014 Apr; 211(4):669-83. PubMed ID: 24638167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.